ASPCF News and Press, Acerus Pharmaceuticals Corp From 06/06/19

Play Video It’s no secret that the healthcare systems in Canada and the US have for years been compared to one another and, as neighboring countries, it’s impossible not to pin the two against each ot...

Acerus Pharmaceuticals Corporation (TSX:ASP, OTCQB: ASPCF) (“Acerus” or the “Company”) today announced that it has reached a mutual agreement with Innovus Pharmaceuticals, Inc. (OTCQB: INNV) (“Innovus Pharma”), a California-based specialty ...

Acerus Pharmaceuticals Corporation (“Acerus” or “the Company”) (TSX:ASP; OTCQB:ASPCF) announced today that it has signed a patent license agreement (the “PLA”) with the University of Texas at Austin for technology related to the nasal administra...

With the 2019 Bloom Burton & Co. Healthcare Investor Conference (BBHIC) officially behind us for another year, one thing was made very clear at this year’s two-day event based on the attendance: sentiment in the life science sectors is stronger than ever. In his opening r...